| ID |
IPI |
Description |
Subcellular localization |
Protein abundance and peptides identification |
GroSize |
ProGroup |
| PM |
Cyto |
Mito |
rER |
sER |
Nucl |
| 301 |
IPI00006213.2 |
Pericentriol material 1 |
Nucl(G2,GO,HPA); Cyto(SP,GO,HPA) |
- |
7.51E-03 (KNHEQLEKIIK;QNSNNTRGNANKTQK) |
- |
1.41E-02 (QNSNNTRGNANKTQK;LPEEEVESSRTPWLYEQEGEVEK;LTIYSEADLR;RQGLAETASPVAVSLR) |
7.59E-03 (DPQQEPMEEIENLK;LTIYSEADLR) |
9.00E-03 (TEYMAFPKPFESSSSIGAEKPR;QNSNNTRGNANKTQK) |
2 |
IPI00006213.2, IPI00795923.1
|
| 302 |
IPI00006250.4 |
Isoform 1 of Short-chain dehydrogenase/reductase 3 |
ER(G1) |
7.50E-02 (AAVGLVLPAK;FPNLFPPLKPETVAR) |
- |
- |
6.55E-01 (AAVGLVLPAK;LGALVMFPLQMIYLVVK;FPNLFPPLKPETVAR;SILPQAALEEIHK;SLMDSDDDALLK;SQHINTLGQFWTTK;VGDITILVNNAAVVHGK;VRFPNLFPPLKPETVAR) |
4.61E-01 (AAVGLVLPAK;LGALVMFPLQMIYLVVK;FPNLFPPLKPETVAR;SILPQAALEEIHK;SQHINTLGQFWTTK;VGDITILVNNAAVVHGK;TVEAVQLNQALLLLPWTMHALVILK;SLMDSDDDALLK) |
- |
1 |
IPI00006250.4
|
| 303 |
IPI00006283.3 |
Isoform 2 of Serine/threonine-protein kinase TAO2 |
Nucl(G1,SP,GO,HPA); Cyto(SP,GO,HPA) |
- |
- |
- |
- |
- |
1.52E-02 (GGALLLLRNSPQPLRR;FVLRERPPTVIMDLIQR) |
1 |
IPI00006283.3
|
| 304 |
IPI00006379.1 |
Nucleolar protein NOP5 |
Nucl(SP,GO,HPA); Cyto(GO) |
5.49E-02 (LGGVIKEK;EKLNLSCIHSPVVNELMRGIR) |
- |
- |
- |
- |
2.39E-01 (IEQVDKEDEITEK;LSELLPEEVEAEVK;TYDPSGDSTLPTCSK;YGLIYHASLVGQTSPK;LIAHAGSLLNLAK;TQLYEYLQNR) |
1 |
IPI00006379.1
|
| 305 |
IPI00006440.5 |
mitochondrial ribosomal protein S7 |
Cyto(G2); Mito(GO,MitoP2) |
- |
2.55E-02 (YHAASAEEQATIER;KTQLIKAAPAGK) |
- |
5.40E-02 (AAPAGKTSSVFEDPVISK;FTNMMMIGGNKVLAR) |
- |
- |
1 |
IPI00006440.5
|
| 306 |
IPI00006442.1 |
Coilin |
Nucl(SP,GO) |
- |
- |
- |
- |
- |
2.61E-02 (DYSLLPLLAAAPQVGEK;LEERGVAENSVVISNGDINLSLRK) |
1 |
IPI00006442.1
|
| 307 |
IPI00006443.2 |
Lambda-crystallin homolog |
Cyto(G1) |
- |
3.51E+00 (EVAGFVLNR;HVLQTFGPIPEFSR;IFAQLDSIIDDR;KIFAQLDSIIDDR;LFAGLVHVK;LYDIEQQQIR;QCIVAHPVNPPYYIPLVELVPHPETAPTTVDR;VPDDPEHLAAR;LQYAIISEAWR;LVEEGIVSPSDLDLVMSEGLGMR;LLEQAGSLK;VILSSSTSCLMPSK;SWAMLFASGGF |
- |
- |
1.11E-01 (HVLQTFGPIPEFSR;LFAGLVHVK;LYDIEQQQIR) |
- |
1 |
IPI00006443.2
|
| 308 |
IPI00006451.5 |
Vesicle-fusing ATPase |
Cyto(SP,GO,HPA) |
- |
5.06E-02 (IDGVEQLNNILVIGMTNRPDLIDEALLRPGR;THPSVVPGSIAFSLPQR;VVNGPEILNK;FSNLVLQALLVLLK;GHQLLSADVDIK;VLDDGELLVQQTK;NFSGAELEGLVR;DFQSGQHVIVR;YVGESEANIR) |
- |
4.29E-02 (IDGVEQLNNILVIGMTNRPDLIDEALLRPGR;FSNLVLQALLVLLK;LLDYVPIGPR;MGIGGLDKEFSDIFR;GHQLLSADVDIK) |
7.48E-02 (GHQLLSADVDIK;MGIGGLDKEFSDIFR;WAGLSIGQEIEVSLYTFDK;AENSSLNLIGK;FSNLVLQALLVLLK;TPLVSVLLEGPPHSGK;VLDDGELLVQQTK) |
1.82E-02 (FSNLVLQALLVLLK;NSDRTPLVSVLLEGPPHSGK) |
1 |
IPI00006451.5
|
| 309 |
IPI00006482.1 |
Isoform Long of Sodium/potassium-transporting ATPase alpha-1 chain precursor |
PM(G1,SP,GO); Mito(MitoP2) |
3.40E+00 (AVAGDASESALLK;AVFQANQENLPILK;DAFQNAYLELGGLGER;DGPNALTPPPTTPEWIK;EQPLDEELKDAFQNAYLELGGLGER;IVEIPFNSTNK;LSLDELHR;NIAFFSTNCVEGTAR;SPDFTNENPLETR;TSATWLALSR;VDNSSLTGESEPQTR;MSINAEEVVVGDLVEVK;GVGI |
- |
5.69E-02 (GVGIISEGNETVEDIAAR;VDNSSLTGESEPQTR) |
5.65E-02 (GVGIISEGNETVEDIAAR;LNIPVSQVNPR;VDNSSLTGESEPQTR;SPDFTNENPLETR;AVFQANQENLPILK) |
7.96E-01 (ADIGVAMGIAGSDVSK;GVGIISEGNETVEDIAAR;KADIGVAMGIAGSDVSK;QGAIVAVTGDGVNDSPALK;VDNSSLTGESEPQTR;LNIPVSQVNPR;AVAGDASESALLK;AVFQANQENLPILK;DGPNALTPPPTTPEWIK;EQPLDEELKDAFQNAYLELGGLGER;IVEIPFNSTNK;MSI |
1.59E+00 (DAFQNAYLELGGLGER;EQPLDEELKDAFQNAYLELGGLGER;IVEIPFNSTNK;VDNSSLTGESEPQTR;AVAGDASESALLK;AVFQANQENLPILK;DGPNALTPPPTTPEWIK;NIAFFSTNCVEGTAR;SPDFTNENPLETR;TSATWLALSR;LSLDELHR;GVGIISEGNETVEDIAAR;LNI |
1 |
IPI00006482.1
|
| 310 |
IPI00006504.3 |
Isoform 1 of Translation initiation factor eIF-2B subunit gamma |
Cyto(G2,GO) |
- |
3.82E-02 (HLVGVDSLIGPETQIGEK;FHTGLVDAHLYCLK;MEFQAVVMAVGGGSR) |
- |
- |
- |
- |
3 |
IPI00006504.3, IPI00217227.3, IPI00332950.5
|
| 311 |
IPI00006547.4 |
T-cell immunomodulatory protein precursor |
PM(G2) |
- |
- |
- |
- |
6.26E-02 (NNFEADAYFVK;SANFLDHLYVGIPR;NDLIVFLADQNAPYFKPK) |
- |
1 |
IPI00006547.4
|
| 312 |
IPI00006579.1 |
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial precursor |
PM(G1); Nucl(GO,HPA); Mito(SP,GO,MitoP2,HPA) |
1.19E+01 (DHPLPEVAHVK;SEDFSLPAYMDR;ASWSSLSMDEK;RDHPLPEVAHVK;HYVYGPLPQSFDK;HYVYGPLPQSFDKEWVAK;VNPIQGLASK) |
- |
5.09E-01 (HYVYGPLPQSFDK;HYVYGPLPQSFDKEWVAK;VNPIQGLASK) |
1.72E-01 (HYVYGPLPQSFDK;SEDFSLPAYMDR;SEDFSLPAYMDRR;FKESFAEMNR) |
7.98E-01 (FKESFAEMNR;HYVYGPLPQSFDK;SEDFSLPAYMDR;VNPIQGLASK) |
5.82E-01 (HYVYGPLPQSFDK;VFSLVGKRAISTSVCVR;HYVYGPLPQSFDKEWVAK) |
1 |
IPI00006579.1
|
| 313 |
IPI00006592.1 |
Peptide methionine sulfoxide reductase |
Cyto(G1) |
- |
4.59E-01 (GVYSTQVGFAGGYTSNPTYK;NPNGYCGLGGTGVSCPVGIK;VLSEHGFGPITTDIR;EGQTFYYAEDYHQQYLSK;VVYQPEHMSFEELLK) |
1.63E-01 (GVYSTQVGFAGGYTSNPTYK;VLSEHGFGPITTDIR;EGQTFYYAEDYHQQYLSK) |
- |
- |
- |
2 |
IPI00006592.1, IPI00796388.1
|
| 314 |
IPI00006610.1 |
Zinc finger BED domain-containing protein 4 |
Cyto(SP,GO); Nucl(SP,GO) |
- |
- |
1.11E-02 (HPEVVGSQKGFLGASLANSPYATLASAESSSSK;ASLFTEEEAEQYKQDLIRELELMNSTSEDVAASHR) |
- |
- |
- |
1 |
IPI00006610.1
|
| 315 |
IPI00006662.1 |
Apolipoprotein D precursor |
Cyto(G1) |
2.93E-01 (CPNPPVQENFDVNK;NILTSNNIDVK) |
2.81E-01 (CPNPPVQENFDVNK;NILTSNNIDVK;IPTTFENGR) |
- |
2.65E-01 (NILTSNNIDVK;NPNLPPETVDSLK) |
1.90E-01 (NILTSNNIDVK;NPNLPPETVDSLK) |
- |
1 |
IPI00006662.1
|
| 316 |
IPI00006663.1 |
Aldehyde dehydrogenase, mitochondrial precursor |
Mito(SP,GO,MitoP2) |
6.25E+00 (AAFQLGSPWR;ANNSTYGLAAAVFTK;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDK;EEIFGPVMQILK;ELGEYGLQAYTEVK;GYFIQPTVFGDVQDGMTIAK;HEPVGVCGQIIPWNFPLLMQAWK;LGPALATGNVVVMK;LLCGGGIAADR;TEQGPQVDETQFK;TFVQEDIYDEFVER;TI |
5.10E+00 (DLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYK;EEIFGPVMQILK;ANNSTYGLAAAVFTK;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDK;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGR;ILGYINTGK;KILGYINTGK;LGPALATGNVVVMK;LLCGGGIAADR;TE |
1.22E+02 (ANYLSQALQAGTVWVNCYDVFGAQSPFGGYK;DLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYK;EEIFGPVMQILK;ANNSTYGLAAAVFTK;FKTIEEVVGR;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDK;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDKVAFTGSTEIGR;ILGYINT |
2.98E-01 (ANNSTYGLAAAVFTK;EEIFGPVMQILK;ELGEYGLQAYTEVK;GYFIQPTVFGDVQDGMTIAK;TEQGPQVDETQFK;TFVQEDIYDEFVER;VAEQTPLTALYVANLIK;VAFTGSTEIGR) |
1.81E-01 (GYFIQPTVFGDVQDGMTIAK;TFVQEDIYDEFVER;VAEQTPLTALYVANLIK;ANNSTYGLAAAVFTK;TIPIDGDFFSYTR;EEIFGPVMQILK;VAFTGSTEIGR;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDK) |
5.57E+00 (DLDKANYLSQALQAGTVWVNCYDVFGAQSPFGGYK;EEIFGPVMQILK;ANNSTYGLAAAVFTK;ANYLSQALQAGTVWVNCYDVFGAQSPFGGYK;EAGFPPGVVNIVPGFGPTAGAAIASHEDVDK;KILGYINTGK;LLCGGGIAADR;TEQGPQVDETQFK;TIPIDGDFFSYTR;VAEQTPLTAL |
1 |
IPI00006663.1
|
| 317 |
IPI00006674.1 |
Isoform 3 of Canalicular multispecific organic anion transporter 2 |
PM(G1,GO) |
5.62E-02 (AVYSDADIFLLDDPLSAVDSHVAK;ILVLDEATAAIDLETDNLIQATIR;SQLTIIPQDPILFSGTLR) |
- |
- |
- |
1.21E-02 (ADGALTQEEKAAIGTVELSVFWDYAK;QLSALSSDGEGQGR) |
1.44E-02 (HIFDHVIGPEGVLAGK;IQQFLSQEELDPQSVER) |
1 |
IPI00006674.1
|
| 318 |
IPI00006684.3 |
Isoform 4 of Apoptosis inhibitor 5 |
Cyto(G1,SP); Nucl(G1,SP,GO,HPA) |
- |
1.55E-02 (GTLGGLFSQILQGEDIVR;NYGILADATEQVGQHK) |
- |
- |
- |
5.98E-01 (GTLGGLFSQILQGEDIVR;LQFSYVECLLYSFHQLGR;NYGILADATEQVGQHK;ELPQFATGENLPR;VADILTQLLQTDDSAEFNLVNNALLSIFK;STVTLSWKPVQK) |
3 |
IPI00006684.3, IPI00554742.1, IPI00555572.1
|
| 319 |
IPI00006707.1 |
Isoform 1 of Pulmonary surfactant-associated protein C precursor |
Mito(G1) |
- |
- |
1.01E-01 (EVLMESPPDYSAAPR;LLIVVVVVVLIVVVIVGALLMGLHMSQK) |
- |
- |
- |
3 |
IPI00006707.1, IPI00218499.1, IPI00792510.1
|
| 320 |
IPI00006713.1 |
Isoform 1 of DnaJ homolog subfamily C member 3 |
ER(G1) |
- |
- |
- |
2.66E-01 (AEAYLIEEMYDEAIQDYETAQEHNENDQQIR;KKFDDGEDPLDAESQQGGGGNPFHR;ISTLYYQLGDHELSLSEVR;KFDDGEDPLDAESQQGGGGNPFHR;LIESAEELIR;LLAAGQLADALSQFHAAVDGDPDNYIAYYR;SNPSENEEKEAQSQLIK;SQALNAFGSGDYTAAIAFLDK;SWNSW |
1.32E-01 (LLAAGQLADALSQFHAAVDGDPDNYIAYYR;SNPSENEEKEAQSQLIK;SQALNAFGSGDYTAAIAFLDK;TEPSIAEYTVR;ISTLYYQLGDHELSLSEVR) |
- |
1 |
IPI00006713.1
|
| 321 |
IPI00006715.3 |
Double-strand-break repair protein rad21 homolog |
Nucl(G1,SP,GO,HPA) |
- |
- |
- |
- |
- |
1.42E+00 (AHVFECNLESSVESIISPK;EFENPEVPREDQQQQHQQR;GGEADNLDEFLK;GGEADNLDEFLKEFENPEVPR;INHLEYEDQYKDDNFGEGNDGGILDDK;LFSLPAQPLWNNR;QQAIELTQEEPYSDIIATPGPR;TGAESISLLELCR;YLLADCNEAFIK;AQLSDYSDIVTTLDLAPPTK;AQ |
1 |
IPI00006715.3
|
| 322 |
IPI00006723.4 |
WD repeat protein 57 |
Nucl(G1) |
- |
- |
- |
- |
- |
8.84E-01 (GHTSFVNSCYPAR;IFQGNVHNFEK;FVYVWDTTSR;VWDVRPFAPK;LPGHAGSINEVAFHPDEPIIISASSDK;LPGHAGSINEVAFHPDEPIIISASSDKR;KAAIQTFQNTYQVLAVTFNDTSDQIISGGIDNDIK;HELLLGAGSGPGAGQQQATPGALLQAGPPR;AAIQTFQNTYQVLAVTFN |
1 |
IPI00006723.4
|
| 323 |
IPI00006725.1 |
Probable ATP-dependent RNA helicase DDX23 |
Nucl(SP,GO,HPA); Mito(HPA); PM(HPA) |
- |
- |
- |
- |
- |
3.94E-02 (LLAILEQGFDPPIIIFVNQK;IEESDQGPYAIILAPTR) |
1 |
IPI00006725.1
|
| 324 |
IPI00006742.1 |
Isoform Alpha of Glycogenin-2 |
Cyto(G1,GO) |
- |
1.49E-01 (LHCWTLTHYSK;LLLQHAMEHGSFDGADQGLLNSFFR;LVVLITPQVSSLLR;KLVVLITPQVSSLLR;CVFLDADTLVLSNVDELFDR) |
- |
- |
- |
- |
6 |
IPI00006742.1, IPI00218983.1, IPI00218984.1, IPI00218985.1, IPI00218986.1, IPI00292838.4
|
| 325 |
IPI00006754.1 |
WD repeat protein 68 |
Nucl(G1,SP,GO,HPA); Cyto(SP,GO,HPA) |
- |
- |
- |
- |
- |
6.19E-02 (GVYPDLLATSGDYLR;HLEHSTIIYEDPQHHPLLR) |
1 |
IPI00006754.1
|
| 326 |
IPI00006865.2 |
Vesicle-trafficking protein SEC22b |
ER(G1) |
3.22E-01 (NLGSINTELQDVQR;PYSFIEFDTFIQK;IMVANIEEVLQR) |
- |
5.20E-02 (NLGSINTELQDVQR;PYSFIEFDTFIQK) |
3.92E+00 (VPTVSRPYSFIEFDTFIQK;IMVANIEEVLQR;KLAFAYLEDLHSEFDEQHGK;KVPTVSRPYSFIEFDTFIQK;LAFAYLEDLHSEFDEQHGK;NLGSINTELQDVQR;PYSFIEFDTFIQK;VADGLPLAASMQEDEQSGR;VLLTMIAR;RNLGSINTELQDVQR;DLQQYQSQAK) |
3.07E+00 (VPTVSRPYSFIEFDTFIQK;IMVANIEEVLQR;KLAFAYLEDLHSEFDEQHGK;KVPTVSRPYSFIEFDTFIQK;LAFAYLEDLHSEFDEQHGK;NLGSINTELQDVQR;PYSFIEFDTFIQK;RNLGSINTELQDVQR;VADGLPLAASMQEDEQSGR;VLLTMIAR;DLQQYQSQAK) |
5.30E-01 (KLAFAYLEDLHSEFDEQHGK;LAFAYLEDLHSEFDEQHGK;VPTVSRPYSFIEFDTFIQK;NLGSINTELQDVQR;PYSFIEFDTFIQK) |
1 |
IPI00006865.2
|
| 327 |
IPI00006920.2 |
HRAS-like suppressor |
Cyto(G2) |
- |
- |
- |
- |
5.80E-02 (ETPGHTQLPPGAR;AISTVEFVTAAVGVFSFLGLFPKGQR) |
- |
1 |
IPI00006920.2
|
| 328 |
IPI00006932.2 |
Isoform 1 of Putative RNA-binding protein Luc7-like 2 |
Nucl(G1) |
- |
1.99E-02 (VEQLGAEGNVEESQK;LHLGFIEIR) |
- |
- |
1.66E-01 (VEQLGAEGNVEESQK;EEIEKLR) |
7.71E-01 (SHLLNCCPHDVLSGTR;VEQLGAEGNVEESQK) |
2 |
IPI00006932.2, IPI00216804.1
|
| 329 |
IPI00006934.1 |
Hydroxyacid oxidase 1 |
Cyto(G1) |
8.44E-01 (AIFVTVDTPYLGNR;GVQDVLEILKEEFR;NVAETDLSTSVLGQR;QLDGVPATIDVLPEIVEAVEGK;SGANDEETLADNIAAFSR) |
1.75E+00 (AIDPSISWEDIK;AIFVTVDTPYLGNR;AVFVGRPIVWGLAFQGEK;GVQDVLEILKEEFR;HGLNGILVSNHGAR;NFETSTLSFSPEENFGDDSGLAAYVAK;LAMALSGCQNVK;LICINDYEQHAK;MAHVDGELATVR;NVAETDLSTSVLGQR;PIVWGLAFQGEK;QLDGVPATIDVLPEIVE |
1.45E-01 (GVQDVLEILKEEFR;HGLNGILVSNHGAR) |
2.16E-01 (AIFVTVDTPYLGNR;GVQDVLEILKEEFR;NVAETDLSTSVLGQR;QLDGVPATIDVLPEIVEAVEGK) |
3.31E-02 (GVQDVLEILKEEFR;ALALGAKAVFVGR) |
2.55E-01 (AIFVTVDTPYLGNR;GVQDVLEILKEEFR;NVAETDLSTSVLGQR;QLDGVPATIDVLPEIVEAVEGK;SGANDEETLADNIAAFSR;GILRGDDAR) |
1 |
IPI00006934.1
|
| 330 |
IPI00006935.2 |
Eukaryotic translation initiation factor 5A-2 |
Cyto(G2,GO) |
- |
4.92E-02 (HGHAKVHLVGIDIFTGK;VHLVGIDIFTGK;VHLVGIDIFTGKK;ADEIDFTTGDAGASSTYPMQCSALR) |
- |
- |
- |
- |
1 |
IPI00006935.2
|
LiverbasePROTEOMESKY-LIVERHu2.0